Entity
  • Evora Biosciences

    Created in 2020


  • Up & running (A)
    Existing signals show a regular activity
  • Social networks

    1,478
  • Activities

  • Technologies

  • Entity types

  • Location

    Strasbourg, France

    Strasbourg

    France

  • Employees

    Scale: 2-10

    Estimated: 10

  • SIREN

    882655699
  • Engaged catalyst

    6
    0 0
  • Added in Motherbase

    1 year, 10 months ago
Description
  • Value proposition

    First-in-class immunomodulatory peptides.

    Evora Biosciences develops novel immunomodulatory peptides with the aim to bring first-in-class treatments to patients in areas of high unmet need.

    immunodermatology, peptides, inflammatory diseases, respiratory diseases, inflammation, and immunomodulation

  • Original language

    First-in-class immunomodulatory peptides.

    Evora Biosciences develops novel immunomodulatory peptides with the aim to bring first-in-class treatments to patients in areas of high unmet need.

Catalyst interactions
Catalyst TypeTweets Articles
Quest for health
Quest for health
Startup accelerator & VC
Quest for health
Startup accelerator & VC
Other

30 Nov 2023


HTGF | High-Tech Gründerfonds
HTGF | High-Tech Gründerfonds
Venture Capital and Private Equity Principals
HTGF | High-Tech Gründerfonds
Venture Capital and Private Equity Principals
Other

16 Oct 2024


BioValley France
BioValley France
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
BioValley France
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
Other

14 Mar 2024


Johnson & Johnson
Johnson & Johnson
Pharmaceutical, Hospitals and Health Care
Johnson & Johnson
Pharmaceutical, Hospitals and Health Care
Other

30 Apr 2023


Erganeo
Erganeo
Research, National and local authorities, Research Services
Erganeo
Research, National and local authorities, Research Services
Other

22 Jun 2023


CNRS Innovation
CNRS Innovation
Research, Research Services
CNRS Innovation
Research, Research Services
Other

29 Jun 2023


Social network dynamics
Similar entities
BETA
Loading...
Loading...